APA aipamena

Mortezavi, A., Salemi, S., Rupp, N. J., Rüschoff, J. H., Hermanns, T., Poyet, C., . . . Eberli, D. (2017). Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death. Oncotarget.

Chicago Style aipamena

Mortezavi, Ashkan, et al. "Negative LC3b Immunoreactivity in Cancer Cells Is an Independent Prognostic Predictor of Prostate Cancer Specific Death." Oncotarget 2017.

MLA aipamena

Mortezavi, Ashkan, et al. "Negative LC3b Immunoreactivity in Cancer Cells Is an Independent Prognostic Predictor of Prostate Cancer Specific Death." Oncotarget 2017.